BlueCrest Capital Management’s Bio-Techne TECH Stock Holding History

BlueCrest Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-8,616	Closed	-$440K	–	1396
2018 Q3	$440K	Buy	+8,616	New	+$382K	0.01%	826
2018 Q2	–	Sell	-11,212	Closed	-$423K	–	1809
2018 Q1	$423K	Buy	+11,212	New	+$396K	0.01%	866
2017 Q4	–	Sell	-15,660	Closed	-$473K	–	1093
2017 Q3	$473K	Sell	15,660 -2,432	-13%	-$72.2K	0.02%	531
2017 Q2	$531K	Buy	+18,092	New	+$494K	0.02%	578
2016 Q3	–	Sell	-32,348	Closed	-$912K	–	985
2016 Q2	$912K	Sell	32,348 -18,436	-36%	-$474K	0.04%	381
2016 Q1	$1.2M	Buy	+50,784	New	+$1.12M	0.07%	342
2015 Q2	–	Sell	-86,836	Closed	-$2.18M	–	905
2015 Q1	$2.18M	Buy	+86,836	New	+$2.06M	0.12%	241

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlueCrest Capital Management's TECH Position: Q4 2018 in Review

BlueCrest Capital Management sold out of Bio-Techne (TECH) in Q4 2018, closing a stake of 8,616 shares — an estimated $440K sold.

BlueCrest Capital Management first reported a position in TECH in Q1 2015 and held it in 7 quarters. The position peaked at $2.18M in Q1 2015. 328 funds tracked by Wall St. Rank hold TECH as of Q4 2018.

BlueCrest Capital Management reported no remaining Bio-Techne position as of Q4 2018 after selling out during the quarter.
BlueCrest Capital Management sold 8,616 Bio-Techne shares in Q4 2018, an estimated $440K.
BlueCrest Capital Management first reported a position in Bio-Techne in Q1 2015 and held it in 7 quarters.
BlueCrest Capital Management's Bio-Techne position peaked at $2.18M in Q1 2015.
328 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.